UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-9 of 9 Help

Filters                
Selected(0)Clear Items/Page:    Sort:
Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation Journal article
FRONTIERS IN PHARMACOLOGY, 2019,Volume: 10
Authors:  Zihao Wang;  Ke-Gang Linghu;  Yuanjia Hu;  Huali Zuo;  Hao Yi;  Shi-Hang Xiong;  Jinjian Lu;  Ging Chan;  Hua Yu;  Run-Yue Huang
Favorite  |  View/Download:15/0  |  Submit date:2019/12/04
Rheumatoid Arthritis  Network Pharmacology  Traditional Chinese Medicine  Huayu-qiangshen-tongbi Formula  In Vitro Validation  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite  |  View/Download:3/0  |  Submit date:2018/10/31
Alzheimer's disease  patent  technology flow  citation network  research and development  
Global patent landscape of programmed cell death 1: implications of the rapid expansion Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 1,Page: 69-80
Authors:  Kong, Xiangjun;  Zhang, Qianru;  Lai, Yunfeng;  Hu, Hao;  Chen, Xin;  Hu, Yuanjia
Favorite  |  View/Download:24/0  |  Submit date:2018/10/30
Programmed Cell Death 1 (Pd-1)  Patent Landscape  Patent Citation Network  Co-patent  Technology Flow  Immunotherapy  
Obstacles and opportunities in Chinese pharmaceutical innovation Journal article
Globalization and Health, 2017,Volume: 13,Issue: 1,Page: 21
Authors:  Ni J.;  Zhao J.;  Ung C.O.L.;  Hu Y.;  Hu H.;  Wang Y.
Favorite  |  View/Download:14/0  |  Submit date:2018/11/06
China  Global Network  Innovation  Obstacles  Opportunities  Pharmaceutical Industry  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
MABS, 2017,Volume: 9,Issue: 7,Page: 1041-1051
Authors:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
Favorite  |  View/Download:13/0  |  Submit date:2018/10/30
Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Pharmaceutical Companies  Technological Innovation  
Analyzing the Chinese landscape in anti-diabetic drug research: Leading knowledge production institutions and thematic communities Journal article
Chinese Medicine (United Kingdom), 2016,Volume: 11,Issue: 1
Authors:  Deng J.;  Sitou K.;  Zhang Y.;  Yan R.;  Hu Y.
Favorite  |  View/Download:6/0  |  Submit date:2018/12/28
Anti-diabetes Drug  Chinese Medicines  Greater China  Network Analysis  Research Collaboration Networks  
Pharmaceutical Technology Licensing: An Analysis in the Field of Cardiovascular Disease Journal article
Journal of Pharmaceutical Innovation, 2016,Volume: 11,Issue: 1,Page: 34
Authors:  Ni J.;  Wan J.;  Kong X.;  Cai Y.;  Yang F.;  Wang Y.;  Hu Y.
Favorite  |  View/Download:5/0  |  Submit date:2018/10/31
Cardiovascular Disease  Network  Pharmaceutical Industry  Technology Licensing  
R&D internationalisation patterns in the global pharmaceutical industry: evidence from a network analytic perspective Journal article
Technology Analysis and Strategic Management, 2015,Volume: 27,Issue: 5,Page: 532
Authors:  Hu Y.;  Scherngell T.;  Qiu L.;  Wang Y.
Favorite  |  View/Download:6/0  |  Submit date:2018/10/31
Pharmaceutical Industry  r&d Networks  Social Network Analysis  
Research and development of anti-Alzheimer’s drugs: an analysis based on technology flows measured by patent citations Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2014,Volume: 24,Issue: 7,Page: 791-800
Authors:  Xu, Jiachen;  Kong, Xiangjun;  Qiu, Lan;  Geng, Xiaomei;  Hu, Yuanjia;  Wang, Yitao
Favorite  |  View/Download:13/0  |  Submit date:2018/11/01
Alzheimer's Disease  Patent Citation Network  Research And Development  Technology Cluster  Technology Flow